Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVelocity Comp Regulatory News (VEL)

Share Price Information for Velocity Comp (VEL)

Share Price is delayed by 15 minutes
Get Live Data
16.00    -0.25 (-1.54%)
Bid:
15.50
Ask:
16.50
Spread: 1.00 (6.452%)
Market Cap: £8.75m
VEL Live PriceLast checked at - London Stock Exchange

Intraday Velocity Comp Share Chart

F1 seventh amendment

29 Dec 2010 12:43

RNS Number : 6636Y
Velti PLC
29 December 2010
 



 

For Immediate Release December 29, 2010

Velti Plc

("Velti" or the "Company")

 

Velti Files Seventh Amendment to Form F-1

Dublin, Ireland - Velti plc ('Velti' or 'the Company'), a leading mobile marketing and advertising technology provider for brands, advertising agencies, mobile operators and media, today announced that it has filed a seventh amendment to its registration statement on Form F-1 previously filed with the United States Securities and Exchange Commission for a proposed initial public offering of its ordinary shares.

Jefferies & Company, Inc. will act as sole book-running manager for the offering with RBC Capital Markets Corporation and Needham & Company, LLC acting as co-lead managers, and ThinkEquity LLC and Cannacord Genuity acting as co-managers. The ordinary shares to be sold in this offering are proposed to be sold by Velti plc and certain of Velti's shareholders. The number of ordinary shares to be sold in the proposed offering and the offering price has not yet been determined.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering will be made only by means of a prospectus.

A copy of the registration statement can be accessed through the Securities and Exchange Commission's web site at www.sec.gov. A written preliminary prospectus related to the offering may be obtained, when available, from the prospectus department of:

Jefferies & Company, Inc., Equity Syndicate Middle Office, Attn: Stephen M. Ficara, 520 Madison Avenue, 12th Floor, New York, NY 10022 (telephone: 212-284-3418/email: sficara@jefferies.com)

END

For further information, please contact:

 

Bankside Consultants

Simon Bloomfield simon.bloomfield@bankside.com

+44 (0) 207 367 8861

 

The Blueshirt Group

Mike Bishop

mike@blueshirtgroup.com

+1 (415) 217 4968

 

RBC Capital Markets

(NOMAD and Broker)

Joshua Critchley

Matthew Coakes

Daniel Conti

+44 (0) 207 653 4000

 

Velti plc

Alex Moukas

Chief Executive Officer

+1 (415) 315 3400

 

Wilson Cheung

Chief Financial Officer

+1 (415) 315 3480

 

Dakota Sullivan

VP, Global Marketing

dsullivan@velti.com

+1 (415) 315 3436

 

About Velti

Velti is a provider of mobile marketing and advertising solutions that enable brands, advertising agencies, mobile operators and media to implement campaigns by communicating with and engaging consumers via their mobile devices. Velti is a publicly-held corporation based in Jersey and trades on the London Stock Exchange's AIM under the symbol VEL.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAAANALAEFFF
Date   Source Headline
26th May 20267:00 amRNSTrading Statement
6th May 20269:07 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSBoard Change
23rd Mar 20262:18 pmRNSGrant of Share Options to Directors/PDMRs
17th Mar 202611:11 amRNSResult of AGM
9th Feb 202612:15 pmRNSChange of Joint Broker
27th Jan 202612:42 pmRNSReplacement - Audited Final Results
27th Jan 20267:00 amRNSFinal Results to the 31 October 2025
13th Jan 20263:49 pmRNS-RNotice of Investor Presentation - Replacement
8th Jan 20267:00 amRNS-RNotice of Investor Presentation
27th Nov 202510:19 amRNSPDMR/Director shareholding
25th Nov 202511:18 amRNSGrant of Share Options to Directors/PDMRs
5th Nov 20257:00 amRNSTrading Update
8th Oct 20257:00 amRNSContract Renewal and Expansion
8th Jul 202510:43 amRNSExercise of Share Options and Issue of Equity
25th Jun 20257:00 amRNSUnaudited Half Year Results
29th May 20257:00 amRNS-RNotice of Investor Presentation
22nd May 20257:00 amRNSTrading Update & Notice of Results
14th May 20253:16 pmRNSExercise of Share Options and Issue of Equity
12th May 20257:00 amRNSRenewal of BAE Systems Contract
6th May 20254:53 pmRNSHolding(s) in Company
6th May 202510:41 amRNSHolding(s) in Company
29th Apr 20255:26 pmRNSExercise of Share Options and Issue of Equity
28th Apr 20254:37 pmRNSPublication of Annual Report and Accounts
28th Mar 20252:49 pmRNSExercise of Share Options and Issue of Equity
17th Mar 20251:51 pmRNSDirector/PDMR Shareholding
11th Mar 202512:15 pmRNSResult of AGM
5th Mar 202510:53 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNS-RAppointment of Chief Operations Officer
3rd Feb 20257:00 amRNSGrant of Share Options
29th Jan 20257:00 amRNSAudited Final Results to 31 October 2024
15th Jan 20257:00 amRNS-RNotice of Investor Presentation
24th Dec 20247:00 amRNSDirector/PDMR Shareholding
20th Dec 20243:26 pmRNSExercise of Share Options and Issue of Equity
12th Dec 20247:00 amRNSTrading Update & Notice of Results
4th Nov 20244:43 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
7th Oct 20247:00 amRNSDirector/PDMR Shareholding
26th Sep 20245:48 pmRNSExercise of Share Options and Issue of Equity
18th Sep 20247:00 amRNSTrading Update
17th Jul 202410:16 amRNSHolding(s) in Company
17th Jul 20247:00 amRNSGrant of Share Options
16th Jul 20247:00 amRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSHalf-Year Results
22nd May 20247:00 amRNSTrading Update & Notice of Results
13th May 20245:12 pmRNSReplacement: Holding(s) in Company
13th May 20242:31 pmRNSHolding(s) in Company
2nd May 20247:00 amRNSChange of Nominated Adviser and Corporate Broker
8th Apr 20244:38 pmRNSDirector/PDMR Shareholding
8th Apr 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.